Search research articles
Contact Us
Filters
Showing results (41-50 of 84) with videos related to
Page
of 9
Sort By:
The Oncologist
|
March 31, 2025
Unmet need for previously untreated metastatic triple-negative breast cancer: a real-world study of patients diagnosed from 2011 to 2022 in the United States
Kevin Punie, Allison W Kurian, Ioanna Ntalla, et al.
Clinical Journal of Oncology Nursing
|
March 19, 2017
Tools for Communication: Novel infrastructure to address patient-perceived gaps in oncology care
Suzanne McMullen, Shelagh Szabo, Ronald J Halbert, et al.
Haematologica
|
November 1, 2015
Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma
Kieron Dunleavy, Stefania Pittaluga, Margaret Shovlin, et al.
Hematological Oncology
|
September 9, 2021
Hypoalbuminemia as a prognostic biomarker for higher mortality and treatment complications in acute myeloid leukemia
Kimberley Doucette, Mary-Elizabeth Percival, Lacey Williams, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 21, 2022
Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19
Michael R Cook, Kaitlyn Dykes, Katherine White, et al.
Journal of Gambling Studies
|
June 2, 2014
Erratum to: A Preliminary Study of an Integrated and Culturally Attuned Cognitive Behavioral Group Treatment for Chinese Problem Gamblers in Hong Kong
Daniel Fu Keung Wong, Catherine Lai Ping Chung, Janet Wu, et al.
Breast Cancer Research and Treatment
|
June 21, 2024
Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States
Kevin Kalinsky, Laura Spring, Clinton Yam, et al.
Leukemia & Lymphoma
|
June 24, 2017
MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R
Catherine Lai, Mark Roschewski, Christopher Melani, et al.
Blood Advances
|
November 27, 2024
Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance)
Catherine Lai, Minji Lee, Olivia Bobek, et al.
Blood Advances
|
July 26, 2022
Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairment
Catherine Lai, Diane E Cole, Seth M Steinberg, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 84) with videos related to
Sort By:
Page
of 9
The Oncologist
|
March 31, 2025
Unmet need for previously untreated metastatic triple-negative breast cancer: a real-world study of patients diagnosed from 2011 to 2022 in the United States
Kevin Punie, Allison W Kurian, Ioanna Ntalla, et al.
Clinical Journal of Oncology Nursing
|
March 19, 2017
Tools for Communication: Novel infrastructure to address patient-perceived gaps in oncology care
Suzanne McMullen, Shelagh Szabo, Ronald J Halbert, et al.
Haematologica
|
November 1, 2015
Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma
Kieron Dunleavy, Stefania Pittaluga, Margaret Shovlin, et al.
Hematological Oncology
|
September 9, 2021
Hypoalbuminemia as a prognostic biomarker for higher mortality and treatment complications in acute myeloid leukemia
Kimberley Doucette, Mary-Elizabeth Percival, Lacey Williams, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 21, 2022
Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19
Michael R Cook, Kaitlyn Dykes, Katherine White, et al.
Journal of Gambling Studies
|
June 2, 2014
Erratum to: A Preliminary Study of an Integrated and Culturally Attuned Cognitive Behavioral Group Treatment for Chinese Problem Gamblers in Hong Kong
Daniel Fu Keung Wong, Catherine Lai Ping Chung, Janet Wu, et al.
Breast Cancer Research and Treatment
|
June 21, 2024
Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States
Kevin Kalinsky, Laura Spring, Clinton Yam, et al.
Leukemia & Lymphoma
|
June 24, 2017
MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R
Catherine Lai, Mark Roschewski, Christopher Melani, et al.
Blood Advances
|
November 27, 2024
Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance)
Catherine Lai, Minji Lee, Olivia Bobek, et al.
Blood Advances
|
July 26, 2022
Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairment
Catherine Lai, Diane E Cole, Seth M Steinberg, et al.
Page
of 9